Trial Profile
Cariprazine pharmacokinetics in volunteers and patients with impaired hepatic function
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 May 2014
Price :
$35
*
At a glance
- Drugs Cariprazine (Primary)
- Indications Bipolar disorders; Schizophrenia
- Focus Pharmacokinetics
- Sponsors Forest Laboratories; Gedeon Richter
- 21 May 2014 New trial record
- 22 Mar 2014 Results presented at the 115th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics.